CYRX
CryoPortCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
The post-earnings company release was materially better than the pre-print monitoring setup: revenue growth accelerated, commercial CGT and services trends stayed strong, adjusted EBITDA improved year over year, and management raised FY26 revenue guidance to $192 million-$196 million from $190 million-$194 million. That supports a modestly stronger positive bias than the April 28, 2026 baseline.
Posture
Mixed
Lead driver
Momentum
What changed
2 setup hits (3d) with net bullish as of 2026-06-03.
What can break
Cryoport remains loss-making despite EBITDA improvement, so any growth slowdown could delay the pathway to profitability.
Momentum
96
Value
41
Sentiment
23
Setup hits (3d)
2 · Net Bullish
AI TargetsBase $12.00 · Bull $14.00 · Bear $8.50
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-04 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Bullish
Target $14.00
Why
Momentum96 · Δ7d +2.0
Value41 · Δ7d +0.1
Sentiment23 · Δ7d -8.1
So what
Balanced signals (Net Bullish). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
96
34% active weight
Current posture
7d trendFlat
Δ7d
+2.0
Δ21d
+4.1
Value
41
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
23
33% active weight
Current posture
7d trendSoftening
Δ7d
-8.1
Δ21d
-9.2
Why this grade
Composite grade C. Momentum 95.9 / Value 41.1 / Sentiment 22.8
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$793.33M
Beta
1.66
Shares Out
50.07M
P/E (TTM)
8.3
P/S (TTM)
2.59
P/FCF (TTM) · Derived
-22.54
Rev YoY
+15.4%
EPS YoY
-546.6%
Gross Margin
+46.6%
Op Margin
-21.4%
Net Debt
-$60.54M
Current Ratio
15.77
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology